• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用潜在类别分析鉴定需要 ECMO 的严重 ARDS 的新型亚表型。

Identification of novel sub-phenotypes of severe ARDS requiring ECMO using latent class analysis.

机构信息

Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Centre for Medical Sciences-CISMed, University of Trento, Trento, Italy.

出版信息

Crit Care. 2024 Oct 24;28(1):343. doi: 10.1186/s13054-024-05143-3.

DOI:10.1186/s13054-024-05143-3
PMID:39449081
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11515347/
Abstract

BACKGROUND

Sub-phenotyping of acute respiratory distress syndrome (ARDS) could be useful for evaluating the severity of ARDS or predicting its responsiveness to given therapeutic strategies, but no studies have yet investigated the heterogeneity of patients with severe ARDS requiring veno-venous extracorporeal membrane oxygenation (V-V ECMO).

METHODS

We conducted this retrospective multicenter observational study in adult patients with severe ARDS treated by V-V ECMO. We performed latent class analysis (LCA) for identifying sub-phenotypes of severe ARDS based on the radiological and clinical findings at the start of ECMO support. Multivariate Cox regression analysis was conducted to investigate the differences in mortality and association between the PEEP setting of ≥ 10 cmHO and mortality by the sub-phenotypes.

RESULTS

We identified three sub-phenotypes from analysis of the data of a total of 544 patients with severe ARDS treated by V-V ECMO, as follows: Dry type (n = 185; 34%); Wet type (n = 169; 31%); and Fibrotic type (n = 190; 35%). The 90-days in-hospital mortality risk was higher in the patients with the Fibrotic type than in those with the Dry type (adjusted hazard ratio [95% confidence interval] 1.75 [1.10-2.79], p = 0.019) or the Wet type (1.50 [1.02-2.23], p = 0.042). The PEEP setting of ≥ 10 cmHO during the first 3 days of ECMO decreased the 90-days in-hospital mortality risk only in patients with the Wet type, and not in those with the Dry or Fibrotic type. A significant interaction effect was observed between the Wet type and the PEEP setting of ≥ 10 cmHO in relation to the 90-day in-hospital mortality (p = 0.036).

CONCLUSIONS

The three sub-phenotypes showed different mortality rates and different relationships between higher PEEP settings in the early phase of V-V ECMO and patient outcomes. Our data suggest that we may need to change our management approach to patients with severe ARDS during V-V ECMO according to their clinical sub-phenotype.

摘要

背景

急性呼吸窘迫综合征(ARDS)的亚表型分型可能有助于评估 ARDS 的严重程度或预测其对特定治疗策略的反应性,但尚无研究探讨需要静脉-静脉体外膜肺氧合(V-V ECMO)治疗的严重 ARDS 患者的异质性。

方法

我们对接受 V-V ECMO 治疗的成人严重 ARDS 患者进行了这项回顾性多中心观察性研究。我们基于 ECMO 支持开始时的影像学和临床发现,进行潜在类别分析(LCA)以确定严重 ARDS 的亚表型。采用多变量 Cox 回归分析探讨死亡率的差异以及亚表型与 PEEP 设置为≥10 cmH2O 与死亡率之间的关联。

结果

我们从总共 544 例接受 V-V ECMO 治疗的严重 ARDS 患者的数据中分析出 3 种亚表型,如下:干燥型(n=185;34%);湿润型(n=169;31%);和纤维化型(n=190;35%)。纤维化型患者的 90 天院内死亡率风险高于干燥型(校正风险比[95%置信区间] 1.75[1.10-2.79],p=0.019)或湿润型(1.50[1.02-2.23],p=0.042)。ECMO 开始后前 3 天的 PEEP 设置为≥10 cmH2O 仅降低了湿润型患者的 90 天院内死亡率风险,而对干燥型或纤维化型患者没有影响。湿型和 PEEP 设置为≥10 cmH2O 与 90 天院内死亡率之间存在显著的交互效应(p=0.036)。

结论

这 3 种亚表型显示出不同的死亡率和 V-V ECMO 早期较高 PEEP 设置与患者结局之间的不同关系。我们的数据表明,根据患者的临床亚表型,我们可能需要改变严重 ARDS 患者接受 V-V ECMO 期间的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9404/11515347/d821ed6c689c/13054_2024_5143_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9404/11515347/51ee17514855/13054_2024_5143_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9404/11515347/9f702ca5fd21/13054_2024_5143_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9404/11515347/d0165d070140/13054_2024_5143_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9404/11515347/d821ed6c689c/13054_2024_5143_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9404/11515347/51ee17514855/13054_2024_5143_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9404/11515347/9f702ca5fd21/13054_2024_5143_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9404/11515347/d0165d070140/13054_2024_5143_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9404/11515347/d821ed6c689c/13054_2024_5143_Fig4_HTML.jpg

相似文献

1
Identification of novel sub-phenotypes of severe ARDS requiring ECMO using latent class analysis.采用潜在类别分析鉴定需要 ECMO 的严重 ARDS 的新型亚表型。
Crit Care. 2024 Oct 24;28(1):343. doi: 10.1186/s13054-024-05143-3.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Extracorporeal membrane oxygenation for critically ill adults.危重症成人的体外膜肺氧合
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD010381. doi: 10.1002/14651858.CD010381.pub2.
4
Extracorporeal carbon dioxide removal for the treatment of acute hypoxaemic respiratory failure: the REST RCT.体外二氧化碳清除治疗急性低氧性呼吸衰竭:REST随机对照试验
Health Technol Assess. 2025 Jul;29(33):1-16. doi: 10.3310/GJDM0320.
5
Sub-phenotypes in patients with out-of-hospital cardiac arrest who undergo extracorporeal cardiopulmonary resuscitation: a retrospective observational study from a multicenter registry.接受体外心肺复苏的院外心脏骤停患者的亚表型:一项来自多中心注册研究的回顾性观察研究。
Crit Care. 2025 Jul 22;29(1):316. doi: 10.1186/s13054-025-05575-5.
6
High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome.机械通气的急性肺损伤和急性呼吸窘迫综合征成年患者的高呼气末正压(PEEP)水平与低呼气末正压水平比较
Cochrane Database Syst Rev. 2013 Jun 6;2013(6):CD009098. doi: 10.1002/14651858.CD009098.pub2.
7
Physiological and clinical effects of two ultraprotective ventilation strategies in patients with veno-venous extracorporeal membrane oxygenation: the ECMOVENT study.两种超保护性通气策略对静脉-静脉体外膜肺氧合患者的生理和临床影响:ECMOVENT研究
Ann Intensive Care. 2025 Aug 1;15(1):111. doi: 10.1186/s13613-025-01525-0.
8
Total bilirubin as a marker for hemolysis and outcome in patients with severe ARDS treated with veno-venous ECMO.总胆红素作为接受静脉-静脉体外膜肺氧合治疗的重症急性呼吸窘迫综合征患者溶血及预后的标志物。
BMC Anesthesiol. 2025 Mar 13;25(1):121. doi: 10.1186/s12871-025-02988-1.
9
Demographics and outcome of Legionella pneumonia in the intensive care unit: a retrospective multicenter cohort study.重症监护病房中军团菌肺炎的人口统计学特征与结局:一项回顾性多中心队列研究
Crit Care. 2025 Aug 20;29(1):372. doi: 10.1186/s13054-025-05524-2.
10
Extracorporeal membrane oxygenation for adult respiratory distress syndrome in trauma patients: A case series and systematic literature review.体外膜肺氧合治疗创伤患者成人呼吸窘迫综合征:病例系列及系统文献综述
J Trauma Acute Care Surg. 2017 Jan;82(1):165-173. doi: 10.1097/TA.0000000000001276.

引用本文的文献

1
Targeting PANoptosis: a promising therapeutic strategy for ALI/ARDS.靶向全程序性细胞死亡:急性肺损伤/急性呼吸窘迫综合征的一种有前景的治疗策略。
Apoptosis. 2025 Sep 4. doi: 10.1007/s10495-025-02168-z.
2
Artificial intelligence and machine learning in acute respiratory distress syndrome management: recent advances.人工智能与机器学习在急性呼吸窘迫综合征管理中的应用:最新进展
Front Med (Lausanne). 2025 Jul 16;12:1597556. doi: 10.3389/fmed.2025.1597556. eCollection 2025.
3
Imaging and pulmonary function techniques in ARDS diagnosis and management: current insights and challenges.

本文引用的文献

1
Chest CT findings in severe acute respiratory distress syndrome requiring V-V ECMO: J-CARVE registry.需要静脉-静脉体外膜肺氧合的严重急性呼吸窘迫综合征的胸部CT表现:J-CARVE注册研究
J Intensive Care. 2024 Jan 26;12(1):5. doi: 10.1186/s40560-023-00715-x.
2
An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline.成人急性呼吸窘迫综合征管理的最新进展:美国胸科学会临床实践指南。
Am J Respir Crit Care Med. 2024 Jan 1;209(1):24-36. doi: 10.1164/rccm.202311-2011ST.
3
Inflammatory subphenotypes in patients at risk of ARDS: evidence from the LIPS-A trial.
急性呼吸窘迫综合征诊断与管理中的影像学和肺功能技术:当前见解与挑战
Crit Care. 2025 Jul 6;29(1):282. doi: 10.1186/s13054-025-05520-6.
4
A narrative review on the future of ARDS: evolving definitions, pathophysiology, and tailored management.关于急性呼吸窘迫综合征未来发展的叙述性综述:不断演变的定义、病理生理学及个性化管理。
Crit Care. 2025 Feb 24;29(1):88. doi: 10.1186/s13054-025-05291-0.
ARDS 风险患者的炎症亚表型:来自 LIPS-A 试验的证据。
Intensive Care Med. 2023 Dec;49(12):1499-1507. doi: 10.1007/s00134-023-07244-z. Epub 2023 Oct 31.
4
Latent class analysis of imaging and clinical respiratory parameters from patients with COVID-19-related ARDS identifies recruitment subphenotypes.基于 COVID-19 相关 ARDS 患者影像学和临床呼吸参数的潜在类别分析可识别出复张亚组。
Crit Care. 2022 Nov 25;26(1):363. doi: 10.1186/s13054-022-04251-2.
5
Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis.基于机器学习模型的临床数据对 ARDS 亚表型的验证和实用性:一项观察性、多队列、回顾性分析。
Lancet Respir Med. 2022 Apr;10(4):367-377. doi: 10.1016/S2213-2600(21)00461-6. Epub 2022 Jan 10.
6
Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids.潜类分析揭示 COVID-19 相关急性呼吸窘迫综合征亚组对皮质类固醇的反应存在差异。
Am J Respir Crit Care Med. 2021 Dec 1;204(11):1274-1285. doi: 10.1164/rccm.202105-1302OC.
7
Management of Adult Patients Supported with Venovenous Extracorporeal Membrane Oxygenation (VV ECMO): Guideline from the Extracorporeal Life Support Organization (ELSO).成人患者静脉-静脉体外膜肺氧合(VV ECMO)支持管理:体外生命支持组织(ELSO)指南。
ASAIO J. 2021 Jun 1;67(6):601-610. doi: 10.1097/MAT.0000000000001432.
8
Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs.深入了解 ECMO、死亡率和 ARDS:一项全国范围内 45647 例 ECMO 运行的分析。
Crit Care. 2021 Jan 28;25(1):38. doi: 10.1186/s13054-021-03463-2.
9
ARDS Subphenotypes: Understanding a Heterogeneous Syndrome.急性呼吸窘迫综合征(ARDS)亚表型:理解一种异质性综合征。
Crit Care. 2020 Mar 24;24(1):102. doi: 10.1186/s13054-020-2778-x.
10
Host-Response Subphenotypes Offer Prognostic Enrichment in Patients With or at Risk for Acute Respiratory Distress Syndrome.宿主反应亚表型为急性呼吸窘迫综合征患者或高危患者提供预后分层。
Crit Care Med. 2019 Dec;47(12):1724-1734. doi: 10.1097/CCM.0000000000004018.